{"entity":{"id":"nct01954316","kind":"trial","name":"A Study of CFI-400945 Fumarate in Patients With Advanced Cancer","aka":[],"tldr":"A phase 1 trial of CFI-400945 run by University Health Network, Toronto, completed.","summary":"A Study of CFI-400945 Fumarate in Patients With Advanced Cancer is a phase 1 interventional study registered as NCT01954316 by University Health Network, Toronto, with 46 participants enrolled, started 2014-03. Conditions recorded: Advanced Cancer. Interventions recorded: CFI-400945.","status":"completed","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT01954316","url":"https://clinicaltrials.gov/study/NCT01954316"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["cfi-400945"],"companies":["treadwell-therapeutics"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT01954316","phase":"1","setting":"An Open Label, Dose Escalation, Safety, and Pharmacokinetic Study of CFI-400945 Fumarate Administered Orally to Patients With Advanced Cancer","sponsor":"University Health Network, Toronto","enrolled":46,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct01954316/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"drug":[{"id":"cfi-400945","kind":"drug","name":"CFI-400945","route":"/drugs/cfi-400945/"}],"company":[{"id":"treadwell-therapeutics","kind":"company","name":"Treadwell Therapeutics","route":"/companies/treadwell-therapeutics/"}]}}